Short answer
LifeStance Health Group, Inc. (LFST) filed an 8-K current report with the SEC on October 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Teresa DeLuca, M.D. resigning from board and all committees effective December 31, 2026.
LifeStance Health Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Teresa DeLuca, M.D. resigning from board and all committees effective December 31, 2026
- Departure not related to disagreement, reducing immediate governance concern
- Board and committee composition changes may affect oversight and director succession planning
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LifeStance Health Group, Inc. 8-K filings
Get the next LFST 8-K as it lands
Follow LFST for push alerts, or ask the research agent what this filing means.